cangrelor: Clinical Trials

13 trials of cangrelor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 2 recruiting, 2 unknown, 1 terminated. 13 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 413Completed 8, Recruiting 2, Unknown 2, Terminated 1

Follow cangrelor: new trials by email Literature Review of cangrelor trials Research Report on cangrelor

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Bridging Antiplatelet Therapy With Cangrelor 2 Study
Cangrelor - Coronary Arterial Disease (CAD)
Phase 4RecruitingUniversity of Florida502026-02-182026-11-06
Effects of Cangrelor on MIcRovAscular Disfunction During Elective Percutaneous CORonary Intervention
Cangrelor 50 MG - Coronary Artery Disease
Phase 4RecruitingFederico II University802023-11-012025-03-13
Pharmacodynamic and Pharmacokinetic of Switching From Cangrelor to Prasugrel in ACS Patients Undergoing PCI
Cangrelor, Prasugrel - Coronary Artery Disease, Acute Coronary Syndrome
Phase 4CompletedUniversity of Florida3592021-02-182024-03-20
PD and PK Profiles of Switching Between Cangrelor and Ticagrelor Following Ticagrelor Pre-treatment
Cangrelor, Placebo - Coronary Artery Disease
Phase 4CompletedUniversity of Florida222021-02-092023-05-16
Cangrelor in Comatose Survivors of OHCA Undergoing Primary PCI
Cangrelor 50 MG - Out-Of-Hospital Cardiac Arrest, Acute Coronary Syndrome
Phase 4CompletedUniversity Medical Centre Ljubljana302019-07-012021-12-03
Cangrelor vs. Ticagrelor for Early Platelet Inhibition in STEMI
Ticagrelor, Cangrelor Tetrasodium - Acute Coronary Syndrome, Myocardial Infarction
Phase 4UnknownUniversity of Aarhus802018-09-012018-06-28
Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial Infarction
Cangrelor, Ticagrelor - Acute Myocardial Infarction, Cardiogenic Shock
Phase 4CompletedFaculty Hospital Kralovske Vinohrady6052018-08-012025-04-02
Platelet Inhibition With Cangrelor and Crushed Ticagrelor in STEMI
Cangrelor, Placebo - ST Segment Elevation Myocardial Infarction, Percutaneous Coronary Intervention
Phase 4CompletedUniversity of Florida502017-11-202020-09-09
Add-on Cangrelor in STEMI-triggered Cardiac Arrest
Cangrelor, Placebo, Prasugrel - Cardiopulmonary Arrest With Successful Resuscitation, ACS - Acute Coronary Syndrome
Phase 4UnknownMedical University of Vienna602017-09-012017-09-13
Cangrelor Following Ticagrelor Loading vs Ticagrelor Loading Alone in STEMI
Ticagrelor 180 mg loading dose, Cangrelor 30 mcg/kg bolus + 4 mcg/kg/min - STEMI
Phase 4CompletedAttikon Hospital302017-07-282017-12-27
Randomized Comparison of Cangrelor, Tirofiban and Prasugrel in Patients With STEMI Referred for Primary PCI.
Cangrelor, Tirofiban, Prasugrel - Coronary Artery Disease, STEMI - ST Elevation Myocardial Infarction
Phase 4CompletedInsel Gruppe AG, University Hospital Bern1222017-07-042020-02-21
Cangrelor in ST-Elevation Myocardial Infarction to Decrease Infarct Size
Cangrelor - STEMI - ST Elevation Myocardial Infarction
Phase 4TerminatedKhaled Ziada, MD232017-01-012020-06-30
The Effect of IV Cangrelor and Oral Ticagrelor Study
Cangrelor, Ticagrelor - Acute Coronary Syndrome (ACS), High On-treatment Platelet Reactivity (HTPR)
Phase 4CompletedThe Royal Wolverhampton Hospitals NHS Trust1002016-07-212025-05-02

Conditions studied

ST Elevation Myocardial Infarction (7)  ·  Acute Coronary Syndrome (5)  ·  Coronary Artery Disease (5)  ·  Myocardial Infarction (2)  ·  Angina, Unstable (1)  ·  Heart Arrest (1)  ·  Hypothermia (1)  ·  Out-of-Hospital Cardiac Arrest (1)  ·  Shock, Cardiogenic (1)

Sponsors

University of Florida (4)  ·  Attikon Hospital (1)  ·  Faculty Hospital Kralovske Vinohrady (1)  ·  Federico II University (1)  ·  Insel Gruppe AG, University Hospital Bern (1)  ·  Khaled Ziada, MD (1)  ·  Medical University of Vienna (1)  ·  The Royal Wolverhampton Hospitals NHS Trust (1)  ·  University Medical Centre Ljubljana (1)  ·  University of Aarhus (1)

Countries

United States (5)  ·  Italy (2)  ·  Austria (1)  ·  Czechia (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Poland (1)  ·  Slovakia (1)  ·  Slovenia (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Francesco Franchi, MD (2)  ·  Deepak L Bhatt, MD, MPH, MBA. (1)  ·  Dimitrios Alexopoulos, MD (1)  ·  Dominick Angiolillo, MD, PhD (1)  ·  Dominick J Angiolillo, MD, PhD (1)  ·  Giuseppe Gargiulo, MD (1)  ·  Jacob T Sorensen, MD, PhD (1)  ·  James Cotton (1)  ·  Khaled Ziada, MD (1)  ·  Luis Ortegra-Paz, MD, PhD (1)  ·  Marco Valgimigli, Prof (1)  ·  Marko Noc, MD PhD (1)  ·  Steen D Kristensen, MD, DMSc (1)  ·  Zuzana Motovska, MD, PhD. (1)

Results publications

PMID 19915221, PMID 19915222, PMID 19923168, PMID 22253393, PMID 23048167, PMID 23473369, PMID 23491524, PMID 23500251, PMID 23768460, PMID 23991622, PMID 25175921, PMID 25660931, PMID 30630341, PMID 31129911, PMID 31466479, PMID 32096064, PMID 32795098, PMID 33258102, PMID 36317958, PMID 37609698, PMID 38335531, PMID 40109258, PMID 41543923

NIH funding

2016 (1), 2018 (1)